Company Profile For Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Limited (Aspen) is a South Africa-based pharmaceuticals company engaged in the manufacture, marketing and distribution of pharmaceutical, branded consumer, personal care and infant milk formulation (IMF) products. The Company operates in six business segments: South Africa-pharmaceutical, South Africa-consumer, East Africa, Latin America, Global brands and Rest of the world. The South African pharmaceutical division comprises prescription generic and pharmaceutical products, over the counter (OTC) products and active pharmaceutical ingredients (APIs). The South African consumer division includes IMFs, self-medication and personal care products. On March 1, 2008, the Company acquired 50% interest in PharmaLatina Holdings Ltd (PharmaLatina). As of June 30, 2009, the Company operated 14 pharmaceutical manufacturing facilities at 10 pharmaceutical manufacturing sites. In June 2009, Aspen divested its entire stake in Astrix Laboratories Ltd.

BRIEF: For the six months ended 31 December 2008, Aspen Pharmacare Holdings Limited's revenues increased 91% to RAN4.26B. Net income increased 56% to RAN684M. Revenues reflect increased income from the pharmaceutical and consumer division. Net income was partially offset by higher cost of sales, increased selling & distribution expenses, higher administrative expenses, higher finance cost and presence of loss from associate.

Aspen Pharmacare Holdings Ltd
Bldg.No.8, Healthcare Park
Woodlands Drive, Woodmead
P O Box1587, Gallo Manor
Johannesburg     2052
P: +2711.2396100
F: +2711.2396111

3144